GoldenGolden
Advanced Search
Immunology

Immunology

Branch of biomedical science studying the immune system

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
July 6, 2021
BioSpace
Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax - read this article along with other careers information, tips and advice on BioSpace
BioSpace
June 23, 2021
BioSpace
Immusoft, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced today the formation of its Scientific Advisory Board (SAB) composed of world-renowned experts to provide external scientific review and high-level counsel on the Company's research and development programs.
Hummingbird Bioscience
June 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets,...
Alex Keown
June 11, 2021
BioSpace
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Kineta, Inc.
June 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today that...
Heather McKenzie
June 4, 2021
BioSpace
Importantly, the researchers recovered virus that they were able to culture, indicating a high risk for transmissibility.
Global Cancer Technology
June 2, 2021
www.prnewswire.com:443
/PRNewswire/ -- Global Cancer Technology--the cancer research company using invisible dots to solve visible problems in healthcare--today announced the...
BioSpace
May 27, 2021
BioSpace
Synbal, Inc., a privately held biotechnology company specializing in the development of genetically complex, humanized mouse models for research announced today that they have received a SBIR grant from the National Institute of Allergy and Infectious Diseases to develop a novel, humanized mouse model for Covid-19 therapeutics research.
Synbal, Inc.
May 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- Synbal, Inc., a privately held biotechnology company specializing in the development of genetically complex, humanized mouse models for...
BioSpace
May 5, 2021
BioSpace
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointments of Maura Gillison, M.D., Ph.D., Professor of Medicine,
Continental Who's Who
May 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Isaac R. Melamed, M.D., is being recognized by Continental Who's Who as a Top Immunologist for the accomplishments he has amassed at the...
February 26, 2021
WebWire
How dangerous are new mutations of the SARS-CoV-2 virus? An international team involving researchers from the Institute of Virology and Immunology (IVI) of the Federal Food Safety and Veterinary Office BLV and the University of Bern (Switzerland), the Centers for Disease Control and Prevention (USA), and the Friedrich-Loeffler Institute (Germany), has developed an approach that can accurately assess the transmissibility of new virus mutants. Prior to the emergence of new mutants of the co...
Amirah Al Idrus
January 19, 2021
FierceBiotech
Gritstone Oncology, the biotech working on cancer vaccines based on traditional infectious disease immunology, is bringing that approach back to its roots. It's working on a vaccine against SARS-CoV-2, the virus that causes COVID-19, that could also work against other viruses in this family in the case of a future pandemic.
Jacob Koshy
January 8, 2021
The Hindu
Dr. Bal, a former scientist of the National Institute of Immunology, says emergency use approval for COVID-19 vaccines over fears of mutant strains is not reasonable on a scientific basis.
Nektar Therapeutics
January 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced today that it has appointed Brian Kotzin, MD as Interim Chief Medical Officer, Head of Development...
Global Research & Discovery Group
December 31, 2020
www.prnewswire.com:443
/PRNewswire/ -- It is with great sadness that Global Research & Discovery Group ("GRDG") announces the passing of Lieutenant Colonel William H. ("Bill")...
3T Biosciences
December 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- 3T Biosciences, an immunotherapy company, today announced that John Connolly, Ph.D. has been appointed as interim CEO. Together with the...
BioSpace
December 1, 2020
BioSpace
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the strengthening of its Scientific Advisory Board ("SAB") with the appointment of leading international experts Dr. Chen Dong and Dr.
I-Mab
December 1, 2020
www.prnewswire.com:443
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization...
Joe Pinkstone
November 13, 2020
Mail Online
Medics reveal a 60-year-old American man with a history of several skin allergies suffered a dermatitis flare up caused by his face mask.
SHOW MORE
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.